Welcome to our blog!

Gentaur bio-list

Best Supplier of Bio Tech Products

Menu

Sars Covid2 Igg Ab Spike Protein

Human IgG F (Ab) Protein

abx061007-5mg 5 mg
EUR 510

Human IgG antibody Laboratories manufactures the sars covid2 igg ab spike protein reagents distributed by Genprice. The Sars Covid2 Igg Ab Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike IgG. Other Sars products are available in stock. Specificity: Sars Category: Covid2 Group: Igg Ab

Human Brucella Antibody IgG (Brucella-Ab-IgG) ELISA Kit

96 Tests
EUR 680
Description: Human (Homo sapiens)

Human H1N1 IgG antibody (H1N1-Ab-IgG) ELISA Kit

48 Tests
EUR 360
Description: Human (Homo sapiens)

Human H1N1 IgG antibody (H1N1-Ab-IgG) ELISA Kit

96 Tests
EUR 680
Description: Human (Homo sapiens)

Human Papillomavirus IgG antibody (HPV-Ab-IgG) ELISA Kit

48 Tests
EUR 360
Description: Human (Homo sapiens)

Human Papillomavirus IgG antibody (HPV-Ab-IgG) ELISA Kit

96 Tests
EUR 680
Description: Human (Homo sapiens)

Human Tuberculosis IgG antibody (TB-Ab-IgG) ELISA Kit

48 Tests
EUR 325
Description: Human (Homo sapiens)

Human Tuberculosis IgG antibody (TB-Ab-IgG) ELISA Kit

96 Tests
EUR 610
Description: Human (Homo sapiens)

Igg Ab information

SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein

10-304 0.1 mg
EUR 632.4
Description: SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein

SARS-CoV-2 (COVID-19) Variant Spike Protein RBD (E484D) Recombinant Protein

21-829 0.1 mg
EUR 714.3
Description: SARS-CoV-2 (COVID-19) Variant Spike Protein RBD (E484D) Recombinant Protein

SARS-CoV-2 (COVID-19) Spike S Trimer Recombinant Protein

20-182 0.1 mg
EUR 651.3
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein (biotin)

21-806 50 ug
EUR 437.1
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells.The SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) is used as antigen in the Serological ELISA Kit to detect anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma (see SARS-CoV-2 (Spike RBD) IgG Serological ELISA Kit; AG-45B-0020).This biotinylated version of SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) forms a tetramer in the presence of streptavidin and this tetramer can be used to activate B cell memory to SARS-CoV-2 Spike protein.

SARS-CoV-2 (COVID-19) Spike E Mosaic Recombinant protein

39-114 0.05 mg
EUR 556.8
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein

20-232 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein

FluoroSpot Path: SARS-CoV-2 (Spike) Human IgG

FSP-05R-S1-1 1 plate
EUR 1176

SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein

10-075 0.1 mg
EUR 991.5
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). The CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells 3-5. Although both SARS-CoV and SARS-CoV-2 bind the ACE2 receptor, the RBDs only share ~73% amino acid identity, and the SARS-CoV-2 RBD binds with a higher affinity compared to SARS-CoV 3, 6. The RBD is dynamic and undergoes hinge-like conformational changes, referred to as the “down” or “up” conformations, which hide or expose the receptor-binding motifs, respectively 7. Following receptor binding, S1 destabilizes, and TMPRSS2 cleaves S2, which undergoes a pre- to post-fusion conformation transition, allowing for membrane fusion 8, 9. The S protein has been the main focus of therapeutic and vaccine design as it is highly immunogenic. Both neutralizing antibodies 10,11 and memory T cells 12,13 targeting the S protein are present in the sera of convalescent COVID-19 patients.

SARS-CoV-2 (COVID-19) Spike RBD + SD1 +SD2 Recombinant Protein

10-305 0.1 mg
EUR 632.4
Description: SARS-CoV-2 (COVID-19) Spike RBD + SD1 +SD2 Recombinant Protein

SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein His Tag

ICOV2STRBDRHIS100UG each
EUR 851
Description: SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein His Tag

SARS-CoV-2 (COVID-19) Biotinylated Spike S1 Recombinant Protein

10-208 0.1 mg
EUR 752.1
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) Biotinylated Spike RBD Recombinant Protein

10-205 0.1 mg
EUR 752.1
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) Spike Glycoprotein-S1, Recombinant protein

39-111 0.05 mg
EUR 1520.7
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

SARS-CoV-2 (COVID-19) Spike Glycoprotein-S2, Recombinant protein

39-112 0.05 mg
EUR 1520.7
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

FluoroSpot Path: SARS-CoV-2 (Spike+RBD) Human IgG

FSP-05R-RS1-1 1 plate
EUR 1417.5

SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein Liquid

ICOV2TRISTR100UG each
EUR 1215
Description: SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein Liquid

SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9]

BSV-COV-AB-01 25 ul
EUR 283
Description: SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] (Spike (S2), Monoclonal)

A nice attention grabbing header!

A descriptive sentence for the Call To Action (CTA).

Contact Us